UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
ViroMed confirms VM202’s pain control in animal test
by Nam Doo-hyun
2018-04-18 11:39
‘Genexine’s pipelines worth more than ₩3 trillion’
by Nam Doo-hyun
2018-04-16 15:48
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma
by Nam Doo-hyun
2018-04-11 14:11
CG Bio wins nod for 3D printed artificial cheekbones
by Nam Doo-hyun
2018-04-10 15:12
Boehringer Ingelheim Korea CEO was forced to resign?
by Nam Doo-hyun
2018-04-06 16:10
라인
Pharmaceutical exports jumped 30% in first two months
by Nam Doo-hyun
2018-04-05 15:09
Invossa’s encouraging trial results presented in US
by Nam Doo-hyun
2018-03-28 15:05
Prescriptions of anticancer drugs surged in January
by Nam Doo-hyun
2018-03-27 14:14
Opdivo adds gastric cancer to indications
by Nam Doo-hyun
2018-03-27 11:34
Stem cell therapy developers unaffected by Cha Biotech debacle
by Nam Doo-hyun
2018-03-26 15:58
라인
4 drugmakers’ profits turn to losses
by Nam Doo-hyun
2018-03-21 11:38
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
by Nam Doo-hyun
2018-03-20 12:01
‘BMS’ Opdivo to lead cancer immunotherapy market’
by Nam Doo-hyun
2018-03-14 15:16
‘Demand for healthcare cloud service rising’
by Nam Doo-hyun
2018-03-12 15:03
‘Me Too’ movement spreads to pharma sector
by Nam Doo-hyun
2018-03-08 11:48
라인
Will Invossa face rival cell gene therapy?
by Nam Doo-hyun
2018-03-07 15:00
‘Order receipt to bolster Samsung BioLogics’ sales’
by Nam Doo-hyun
2018-03-06 15:58
Researchers find diagnostic biomarker for type 2 diabetes
by Nam Doo-hyun
2018-03-05 12:16
Seoul spent ₩2 trillion for new drug development in 7 years
by Nam Doo-hyun
2018-03-02 11:59
‘Korea needs genome data standardization'
by Nam Doo-hyun
2018-02-28 11:31
-
1
2
3
4
5
6
7
8
9
10
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top